secwatch / observer
8-K filed June 1, 2026, 6:56 AM ET ticker INAB CIK 0001740279
other material confidence high sentiment neutral materiality 0.50

IN8bio enters new ATM equity facility with JonesTrading, terminates prior Cantor agreement

IN8BIO, INC.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IN8BIO, INC. terminated Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. (effective 2026-05-29).

Action
termination
Agreement
atm program
Counterparty
Cantor Fitzgerald & Co.
Effective
2026-05-29
Exact text from the filing
On May 29, 2026, the Company and Cantor mutually agreed to terminate the Cantor Sales Agreement and the offering of shares contemplated thereby, effective at the close of business on May 29, 2026, pursuant to Sections 12(b) and 12(c) of the Cantor Sales Agreement.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IN8BIO, INC. entered into Capital on Demand TM Sales Agreement with JonesTrading Institutional Services LLC (effective 2026-06-01).

Action
entry
Agreement
atm program
Counterparty
JonesTrading Institutional Services LLC
Effective
2026-06-01
Exact text from the filing
On June 1, 2026, IN8bio, Inc. (the “ Company ”) entered into a Capital on Demand TM Sales Agreement (the “ Sales Agreement ”) with JonesTrading Institutional Services LLC (the “ Agent ”) with respect to an at the market offering program under which the Company may issue and sell, from time to time at its sole discretion, shares (the “ Placement Shares ”) of its common stock, par value $0.0001 per share (the “ Common Stock ”), through or to the Agent.
View on SEC.gov

Browse all material agreements →

IN8BIO, INC. filing history →

Source: SEC EDGAR
accession 0001193125-26-249684
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.